Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 14/20 | 1.00 |
| ▸ | HTR2B | P41595 | 13/20 | 1.00 |
| ▸ | HTR2C | P28335 | 13/20 | 1.00 |
| ▸ | HTR7 | P34969 | 12/20 | 1.00 |
| ▸ | HTR1A | P08908 | 11/20 | 1.00 |
| ▸ | DRD1 | P21728 | 6/20 | 1.00 |
| ▸ | DRD2 | P14416 | 5/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 1.00 |
| ▸ | TDP2 | O95551 | 2/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 1.00 |
| ▸ | MAPT | P10636 | 2/20 | 1.00 |
| ▸ | CASP3 | P42574 | 2/20 | 1.00 |
| ▸ | RAD52 | P43351 | 2/20 | 1.00 |
| ▸ | SENP8 | Q96LD8 | 2/20 | 1.00 |
| ▸ | SENP7 | Q9BQF6 | 2/20 | 1.00 |
| ▸ | SENP6 | Q9GZR1 | 2/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 1.00 |
| ▸ | PTPRCAP | Q14761 | 1/20 | 1.00 |
| ▸ | APAF1 | O14727 | 1/20 | 0.97 |
| ▸ | HPGD | P15428 | 1/20 | 0.97 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glaucine SCHEMBL29735463 | 1.00 | HTR2A (1.00) | HTR2AHTR2BHTR2CHTR7HTR1A | |
| Glaucine SCHEMBL30213021 | 1.00 | HTR2A (1.00) | HTR2AHTR2BHTR2CHTR7HTR1A | |
| Glaucine SCHEMBL3040938 | 1.00 | HTR2A (1.00) | HTR2AHTR2BHTR2CHTR7HTR1A | |
| Glaucine SCHEMBL11158386 | 0.99 | KDM4E (1.00) | HTR2AHTR2BHTR2CHTR7HTR1A | |
| Glaucine SCHEMBL11249152 | 0.99 | KDM4E (1.00) | HTR2AHTR2BHTR2CHTR7HTR1A | |
| Glaucine SCHEMBL11166124 | 0.99 | HTR2A (0.97) | HTR2AHTR2BHTR2CHTR7HTR1A | |
| Glaucine SCHEMBL4312401 | 0.94 | HTR2A (0.88) | HTR2AHTR2BHTR2CHTR7HTR1A | |
| Glaucine SCHEMBL7389697 | 0.93 | HTR2B (0.86) | HTR2AHTR2BHTR2CHTR7HTR1A | |
| SCHEMBL4854015 | 0.92 | HTR7 (1.00) | HTR2AHTR2BHTR2CHTR7HTR1A | |
| SCHEMBL30475142 | 0.92 | HTR7 (1.00) | HTR2AHTR2BHTR2CHTR7HTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1186 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250255781-A1 | PROCESSES FOR PREPARATION OF 3-D PRINTED PHARMACEUTICAL PRODUCTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-08-14 | — | — | US | claimed |
| US-12296043-B2 | Liquisoft capsules | PATHEON SOFTGELS INC. (US) | 2025-05-13 | — | — | US | claimed |
| EP-4510999-A1 | PROCESSES FOR PREPARATION OF 3-D PRINTED PHARMACEUTICAL PRODUCTS | Bristol-Myers Squibb Company (US) | 2025-02-26 | — | — | EP | claimed |
| US-20250051862-A1 | METHODS AND COMPOSITIONS RELATED TO ENGINEERED BIOSENSORS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2025-02-13 | — | — | US | claimed |
| CN-119212681-A | Method for preparing 3-D printed pharmaceutical products | 百时美施贵宝公司 | 2024-12-27 | — | — | CN | claimed |
| US-20240316015-A1 | COMPOSITION AND METHOD FOR TREATING TUMORS | NATURAL MEDICINE INSTITUTE OF ZHEJIANG YANGSHENGTANG CO., LTD. (CN) | 2024-09-26 | — | — | US | claimed |
| US-20240279645-A1 | METHODS AND COMPOSITIONS RELATED TO A MODIFIED METHYLTRANSFERASE | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2024-08-22 | — | — | US | claimed |
| US-20240261252-A1 | Methods of use and formulations of allosteric modulators of the serotonin, dopamine and other receptor systems for medical, recreational, religious, research and other uses. | HELDRETH JR DAVID ALAN (US) | 2024-08-08 | — | — | US | claimed |
| US-20240165020-A1 | LIQUISOFT CAPSULES | PATHEON SOFTGELS INC (US) | 2024-05-23 | — | — | US | claimed |
| EP-4360653-A2 | LIQUISOFT CAPSULES | Patheon Softgels Inc. (US) | 2024-05-01 | — | — | EP | claimed |
| EP-0618972-A1 | CONSTITUTIVE EXPRESSION OF P450SOY AND FERREDOXIN-SOY IN $i(STREPTOMYCES), AND BIOTRANSFORMATION OF CHEMICALS BY RECOMBINANT ORGANISMS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1994-10-12 | — | — | EP | claimed |
| US-5256190-A | Comprising a plate coating, fountain concentrates, an alcohol replacement, a roller coating, plate wash and compensator solution | BARTH THOMAS M (US) | 1993-10-26 | — | — | US | claimed |
| WO-1993012236-A1 | CONSTITUTIVE EXPRESSION OF P450SOY AND FERREDOXIN-SOY IN STREPTOMYCES, AND BIOTRANSFORMATION OF CHEMICALS BY RECOMBINANT ORGANISMS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1993-06-24 | — | — | WO | claimed |
| US-5156847-A | Aporphinoid alkaloid in nonaqueous solvent | Lewis, Walter H. (US) | 1992-10-20 | — | — | US | claimed |
| US-4370331-A | L-Glaucine containing composition for cough relief | KARL O. HELM AKTIENGESELLSCHAFT (DE) | 1983-01-25 | — | — | US | claimed |
| US-4315010-A | ANTITUSSIVE | THE DOW CHEMICAL COMPANY (US) | 1982-02-09 | — | — | US | claimed |
| US-4279914-A | 1-GLAUCINE OR TETRAHYDROXYAPORPHINE, ANTICOAGULANTS | HERMANN GOTTFRIED SCHNABEL FA. (DE) | 1981-07-21 | — | — | US | claimed |
| US-4265912-A | Glaucine lactate salts | THE DOW CHEMICAL COMPANY (US) | 1981-05-05 | — | — | US | claimed |
| US-4185119-A | Antiallergic methods | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1980-01-22 | — | — | US | claimed |
| US-4183939-A | Glaucine analgesic method | THE DOW CHEMICAL COMPANY (US) | 1980-01-15 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240316015-A1 | COMPOSITION AND METHOD FOR TREATING TUMORS | PDE4B, PDE4A, PDE4C | HTR2A 4201/4885HTR2B 3431/4885HTR2C 4141/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.